Article

Knockout of Noxa with CRISPR/Cas9 Increases Host Resistance to Influenza Virus Infection

Cellular Microbiology · 2022 · Ao Zhou, author Wenhua Zhang, author Baoxin Wang, author Xia Dong, author Jing Zhang, author Hongbo Chen, author Jayaprakash Narayana Kolla, Academic Editor

Key facts

Title Knockout of Noxa with CRISPR/Cas9 Increases Host Resistance to Influenza Virus Infection
First author Ao Zhou, author Wenhua Zhang, author Baoxin Wang, author Xia Dong, author Jing Zhang, author Hongbo Chen, author Jayaprakash Narayana Kolla, Academic Editor
Journal Cellular Microbiology
Published Oct 19, 2022
DOI 10.1155/2023/3877614
Devices mentioned BK110039, DEN000008, K022086, K103302
Product codes mentioned JCI, KIP, KIT, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature